Amit Kumar Buys $52.5K of Anixa Biosciences Inc (ANIX) — SEC Form 4, Jun 16, 2026

Open-Market Net Purchase · SEC Form 4
+$52,500

Equity position changed by +3.4%

Reporting Owner
Amit Kumar
CEO
TXN 2026-06-12 · FILED 2026-06-16
Equity Position 631K sh 609,812 → 630,812
Equity Change +3.4% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Anixa Biosciences Inc

ANIX CIK 0000715446
All Anixa Biosciences Inc insider activity
Filing Date
2026-06-16
Report Date
2026-06-16
Accession No.
0001493152-26-028827
Accepted At
2026-06-16 13:00 UTC
Reporting Owner
Name Relationship
Amit Kumar CIK 0001191905
Director CEO
Amit Kumar at Anixa Biosciences Inc Full insider history
Bought (12 mo) $220,604
Sold (12 mo) —
More from this insider at Anixa Biosciences Inc
2026-11-02 Buy +$15,850 View
2026-10-22 Buy +$21,760 View
2026-09-28 Buy +$19,460 View
2026-09-14 Buy +$8,250 View
2026-09-11 Buy +$13,800 View
All filings by this insider at Anixa Biosciences Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common Stock 2026-06-12 P - Purchase 21,000 A $2.50 +$52,500 630,812 Direct

Related filings at Anixa Biosciences Inc

Institutional Holders
13F holders · Jun 30, 2026 64 institutional managers reporting a position
Largest by reported value
  1. Vanguard Capital Management Llc $3.72M
  2. Ubs Group Ag $1.64M
  3. Laird Norton Trust Company, Llc $1.62M
5%+ Holders · 13D/G 2 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Anixa Biosciences Inc
All Anixa Biosciences Inc insider activity
GET /v1/forms/4/0001493152-26-028827 API docs
View Original SEC Filing